DCVC Bio

Funding rounds backed by DCVC Bio.

Export CSV
Funding disclosed in full
$248.4M
Median round
$97M
Rounds in calculation
3
3 rounds
LatestLargest
Funding rounds with company descriptions, amounts, stages and announcement dates
CompanyRoundMarketInvestorsAnnouncedDetails
Syntax Bio

Develops cell therapies using proprietary Cellgorithm platform for regenerative medicine

$14.4MSeries A+BiotechUnited States
16 participantsAllegis CapitalAstellas Venture ManagementCivilization VenturesDCVC BioDraper AssociatesEGB CapitalExit FundIllinois VenturesIllumina VenturesLongGameMansueto OfficeMayo ClinicPortal InnovationsSigma Groupthe Illinois Department of Commerce and Economic OpportunityWalder Ventures
Latus Bio, Inc.

Engineers scalable AAV gene therapies for CNS and rare diseases including Huntington's disease and CLN2

$97MSeries ABiotechUnited States
9 participants8VCBenjamin Franklin Technology PartnersBioAdvanceDCVC BioGaingelsHatch BioFundHelen's Pink Sky FoundationKorea Development BankModi Ventures
Sidewinder Therapeutics

Develops next-generation bispecific ADCs for cancer treatment

$137MSeries BBiotechUnited States
9 participantsAlexandria Real Estate EquitiesAstellas Venture ManagementDCVC BioFrazier Life SciencesGoldman Sachs Alternatives Life SciencesLongwood FundNovartis Venture FundOrbiMedSamsara BioCapital